חוב לטווח קצר של החברה: Cytori Therapeutics (PSTV)

A critical dependence on external laboratories and isotope suppliers impacts the financial stability of Plus Therapeutics, Inc. (PSTV). The evolution of short-term debt load demonstrates the dynamics of liabilities, where 0.00 is recorded as the baseline value. Management is focusing on trials for brain tumor treatments, while high hospital demand for targeted breast cancer therapy is driving business development.

Short-term debt measures the total volume of obligations due within one year, allowing for an assessment of the risk of losing operational liquidity and the probability of a cash crunch. By analyzing the structure of short-term liabilities, an investor can determine the extent to which the financial stability of Plus Therapeutics, Inc. (PSTV) depends on payment discipline toward external CMO laboratories and CRO centers that provide the critical synthesis of radiopharmaceuticals.